Vial: difference between revisions
Diff·revision 45 → 46·13:04, 1 Jun 2025
Difference between revision 45 and revision 46 of Vial. 5 lines changed; the page grew by 344 bytes.
| Revision 45 — 18:21, 21 May 2025 CrudePeptidePearl (talk) expand §Delamination and glass defects 19,929 bytes +187 | Revision 46 — 13:04, 1 Jun 2025 CouplingCillian (talk) remove weasel wording 20,273 bytes +344 | ||
|---|---|---|---|
| 148 | <ref name="kirsch1997">Kirsch LE, Nguyen L, Moeckly CS. "Pharmaceutical container/closure integrity I: mass spectrometry-based helium leak rate detection for rubber-stoppered glass vials." ''PDA Journal of Pharmaceutical Science and Technology'' 51(5):187–194 (1997).</ref> | 148 | <ref name="kirsch1997">Kirsch LE, Nguyen L, Moeckly CS. "Pharmaceutical container/closure integrity I: mass spectrometry-based helium leak rate detection for rubber-stoppered glass vials." ''PDA Journal of Pharmaceutical Science and Technology'' 51(5):187–194 (1997).</ref> |
| 149 | 149 | ||
| + | 150 | == Further reading == | |
| + | 151 | * Sacha GA, Saffell-Clemmer W, Abram K, Akers MJ. "Practical fundamentals of glass, rubber, and plastic sterile packaging systems." ''Pharmaceutical Development and Technology'' 15(1):6–34 (2010). | |
| + | 152 | * Guazzo DM. "Container closure integrity testing" in ''Sterile Product Development'', Springer (2013). | |
| + | 153 | ||
| 150 | == See also == | 154 | == See also == |
| 151 | * [[Multi-dose vial]] | 155 | * [[Multi-dose vial]] |
| ⋮ | ⋮ | ||
| 155 | * [[Reconstitution of lyophilised peptides]] | 159 | * [[Reconstitution of lyophilised peptides]] |
| 156 | * [[Underfilling]] | 160 | * [[Underfilling]] |
| + | 161 | * [[Repackaging]] | |
| 157 | 162 | ||
| 158 | {{DEFAULTSORT:Vial}} | 163 | {{DEFAULTSORT:Vial}} |